RhoC Gene Overexpression in Pancreatic Cancer
Author Information
Author(s): H Suwal, G Ohshio, T Imamura, G Watanabe, S Arii, M Imamura, S Narumiya, H Hiai, M Fukumoto
Primary Institution: Kyoto University
Hypothesis
The study investigates the role of rhoC gene expression in the progression of pancreatic ductal adenocarcinoma.
Conclusion
Overexpression of the rhoC gene is associated with poorer prognosis in patients with pancreatic adenocarcinoma.
Supporting Evidence
- The rhoC gene was significantly overexpressed in tumor tissues compared to non-malignant portions.
- Patients with high rhoC expression had poorer survival rates.
- Metastatic lesions showed higher rhoC expression than primary tumors.
Takeaway
This study found that a gene called rhoC is more active in pancreatic cancer, and when it's more active, patients tend to do worse.
Methodology
The study used RT-PCR to measure rho gene expressions in tumor tissues and compared them with non-malignant portions.
Limitations
The study could not compare matched pairs of primary and metastatic lesions.
Participant Demographics
Patients with ductal adenocarcinoma of the pancreas, ages ranging from 46 to 79.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website